YCBD Earnings cbdMD, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–29 of 29
| FY 2025 | 2025-09-30 | -1.09 | 2025-12-19 | 10-K |
| FY 2025 | 2024-09-30 | -14.29 | 2025-12-19 | 10-K |
| Q3 2024 | 2024-06-30 | -1.84 | 2024-08-14 | 10-Q |
| Q2 2024 | 2024-03-31 | -2.03 | 2024-05-15 | 10-Q |
| FY 2024 | 2023-09-30 | -13.32 | 2024-12-18 | 10-K |
| Q3 2024 | 2023-06-30 | -4.26 | 2024-08-14 | 10-Q |
| Q2 2024 | 2023-03-31 | -5.43 | 2024-05-15 | 10-Q |
| Q1 2023 | 2022-12-31 | -0.08 | 2023-02-13 | 10-Q |
| FY 2023 | 2022-09-30 | -55.80 | 2023-12-22 | 10-K |
| Q3 2023 | 2022-06-30 | -44.41 | 2023-08-10 | 10-Q |
| Q2 2023 | 2022-03-31 | -19.67 | 2023-05-15 | 10-Q |
| Q1 2023 | 2021-12-31 | -0.35 | 2023-02-13 | 10-Q |
| FY 2022 | 2021-09-30 | -0.47 | 2022-12-15 | 10-K |
| Q3 2022 | 2021-06-30 | -0.40 | 2022-08-11 | 10-Q |
| Q2 2022 | 2021-03-31 | -0.43 | 2022-05-13 | 10-Q |
| Q1 2022 | 2020-12-31 | -0.18 | 2022-02-10 | 10-Q |
| FY 2021 | 2020-09-30 | 0.28 | 2021-12-17 | 10-K |
| Q3 2021 | 2020-06-30 | 0.44 | 2021-08-12 | 10-Q |
| Q2 2021 | 2020-03-31 | 0.74 | 2021-05-12 | 10-Q |
| Q1 2021 | 2019-12-31 | 0.45 | 2021-02-09 | 10-Q |
| FY 2020 | 2019-09-30 | 0.00 | 2020-12-22 | 10-K |
| Q3 2020 | 2019-06-30 | 0.00 | 2020-08-12 | 10-Q |
| Q2 2020 | 2019-03-31 | 0.00 | 2020-05-15 | 10-Q |
| Q1 2020 | 2018-12-31 | 0.00 | 2020-02-13 | 10-Q |
| FY 2019 | 2018-09-30 | 0.00 | 2019-12-18 | 10-K |
| Q3 2019 | 2018-06-30 | 0.06 | 2019-08-14 | 10-Q |
| Q2 2019 | 2018-03-31 | 0.04 | 2019-05-15 | 10-Q |
| Q3 2018 | 2017-06-30 | 0.00 | 2018-08-14 | 10-Q |
| Q2 2018 | 2017-03-31 | -0.31 | 2018-05-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.